About VIB (140)
Bio imaging core (1)
Business opportunities (16)
Cardiovascular medicine (25)
Cell biology (13)
Developmental biology (4)
Inflammation and immunity (78)
International PhD Program (1)
Model Organisms (4)
Plant biology (86)
Research Areas (5)
Science ethics (2)
Structural biology (27)
BioInformatics Training and Service facility (1)
Research services (5)
Systems biology (3)
Page Content Zone 1
Lipidomics paves the way to groundbreaking scientific discoveries
25 April 2017
By expanding VIB’s network of technology suppliers, purchasing licenses and negotiating business partnerships, the Tech Watch team enables VIB scientists to have privileged access to cutting-edge scientific innovations.
Metastatic breast cancers: Characterising the profile of metastases for improved treatment
24 April 2017
Researchers at the Jules Bordet Institute, ULB, VIB and KU Leuven published a study offering a better understanding of the progression of breast cancer. The conclusions could have an impact on care for patients suffering from a metastatic breast cancer
Speaking up for animal research
22 April 2017
Young researchers from within and outside of VIB got founded ‘Infopunt Proefdieronderzoek’ (Dutch for Animal Research Info Point). Through a web platform and social media presence, they aim to provide up-to-date and clear information on animal research.
The Baillet Latour Grant 2017 for Medical Research awarded to professor Roosmarijn Vandenbroucke (VIB-UGent)
20 April 2017
This year the Grant is awarded to Professor Roosmarijn Vandenbroucke for her research project in the field of neurological diseases. Delivery of therapeutics into the brain to treat neurological diseases remains a major, unsolved challenge.
Multiplexing CRISPR: thousands of mutations, endless possibilities for discovery
15 April 2017
While basic CRISPR experiments are already transforming life sciences research, there are many emerging CRISPR tools that open up previously unimaginable opportunities.
Specialized blood vessels enhance tumor-fighting immunotherapy
12 April 2017
Scientists from VIB and KU Leuven, together with colleagues from the University of California and the Swiss Institute for Experimental Cancer Research have demonstrated that , anti-angiogenic therapy can improve immune boosting treatments.
Quickscan VIBnews March 2017
8 April 2017
Quickscan scientific publications
Scientists expose protein responsible for allergic diseases
4 April 2017
Scientists at VIB-UGent have managed to unravel the functioning of what is thought to be the ‘master protein’ that drives a range of widespread allergic diseases, such as asthma and eczema.
Bringing the core of fundamental Life science to the forefront
1 April 2017
The immunology lab of Bart Lambrecht and Hamida Hammad (VIB-UGent Center for Inflammation Research) is constantly churning out groundbreaking new insights relevant to a wide range of disease-fighting applications.
200 years of Parkinson's research
29 March 2017
2017 marks the 200th anniversary of James Parkinson’s description of the disease that now bears his name and that affects an estimated 5 million people worldwide. In 1817, he published his findings in his seminal ‘Essay on shaking palsy’.
VIB and DNAlytics team up to develop non-invasive Colorectal Cancer screening test
24 March 2017
Based on a research program from VIB, KU Leuven and UZ Leuven, with the support of the Fournier Majoie Foundation, DNAlytics will develop the ColonoKit which should make it possible to detect colorectal cancer in an early stage using a simple blood test.
Competitive ERC Advanced Grant awarded to Peter Carmeliet for Tumor Endothelial Cell research
23 March 2017
Prof. Peter Carmeliet (VIB-KU Leuven) is awarded an Advanced Grant. To qualify, a scientist has to be able to prove exceptional leadership and a solid track record of significant research achievements over at least 10 years.
Novel insights confirm pivotal role of synapse in development of Parkinson’s disease
22 March 2017
Roeland Vanhauwaert and Dr. Sandra-Fausia Soukup and colleagues from the Patrik Verstreken Lab (VIB-KU Leuven) modelled a new Parkinson mutation in fruit flies and in differentiated iPS cells from different patients.
PHD2 targeting overcomes breast cancer cell death upon glucose starvation
21 March 2017
The Massimiliano Mazzone group (VIB-KU Leuven) has recently demonstrated that PP2A/B55α promotes the growth of colorectal cancer, by dephosphorylating PHD2 and modifying its enzymatic properties.
Stellar cross-domain insights from Peter Carmeliet and his team
20 March 2017
Researchers from the lab of Peter Carmeliet (VIB-KU Leuven) made an unexpected discovery: the meninges, previously thought to be simply a protective membrane on the outer surface of the brain, actually contains cells that give rise to neurons.
Page Content Zone 2
Page Content Zone 3
Get news updates:
Follow us on Twitter
Like us on Facebook
Inflammation and immunity
Training and facilities
Int. Ph.D. Program